A targeted new drug for a rare and aggressive form of lung cancer will be fast-tracked to eligible patients within weeks, thanks to a deal brokered by NHS England. Patients in England will be the first in Europe to access Mobocertinib – the only precision drug available to patients with a mutation-driven, advanced form of […]

A life-extending injection for a fatal form of blood cancer will be available to around 350 patients per year in England, the NHS chief executive has announced. The drug, which can extend the lives of patients with a recurring and incurable cancer of the bone marrow cells – known as multiple myeloma – by an […]

One of the first patients to access a ground-breaking treatment for sickle cell disease on the NHS says she is “over the moon” to have received the “lifechanging” new drug. Loury Mooruth, 62, from Walsall in the West Midlands, is one of the first people to receive crizanlizumab at Birmingham NHS Trust – the first […]

Victims and survivors of sexual and domestic abuse are being encouraged to come forward for NHS help and care, as part of a major campaign backed by a £20 million boost to specialist services. Two new clinical lead roles for domestic violence and sexual assault are also being created, alongside dedicated domestic violence support for […]

The NHS has struck a deal for a life-saving treatment, reportedly the most expensive drug in the world, that will offer babies and young children with a rare and fatal genetic disease the prospect of a normal life, the health service chief executive has announced today. The revolutionary gene therapy treatment is known by its […]

Thousands of lung cancer patients in England will be fast-tracked a ground-breaking new drug which can significantly reduce the risk of cancer returning, thanks to a deal brokered by NHS England. The MHRA has now approved the effective therapy, atezolizumab, to treat non-small cell lung cancer (NSCLC), with more than 850 patients in England expected […]

Thousands of children and young people will receive a pioneering treatment for peanut allergy after NHS England secured the first deal of its kind in Europe. The treatment, known as Palforzia, helps to reduce the severity of reactions to peanuts – including anaphylaxis – making family holidays abroad, birthday parties, and Christmas treats possible for […]

A five-month old baby has become the first patient to receive a potentially life-saving drug on the NHS that can prevent paralysis and prolong the lives of children with Spinal Muscular Atrophy (SMA). Arthur Morgan, who was diagnosed with SMA earlier this month, received the one-off gene therapy at Evelina London Children’s Hospital on May […]

A world-leading treatment that halves the risk of lung cancer patients suffering a return of the disease after undergoing treatment, is to be rolled out by NHS England. In a trial of the drug – the first of its kind – around nine out of ten patients treated, remained alive and disease-free after two years […]

NHS England has today announced it has secured a definitive agreement with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines. This means NHS patients will now have full access to Orkambi, Symkevi and Kalydeco, and around 5000 people may now take up these treatments. There is no cap on patient numbers, and each and every patient in England who […]